التفاصيل البيبلوغرافية
العنوان: |
Use of the Site of Subcutaneous Insulin Administration for the Measurement of Glucose in Patients With Type 1 Diabetes |
المؤلفون: |
Stefan Lindpointner, Hans Köhler, Roland Schaller, Lukas Schaupp, Martin Ellmerer, Thomas R. Pieber, Werner Regittnig |
المساهمون: |
The Pennsylvania State University CiteSeerX Archives |
المصدر: |
ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/50/d5/Diabetes_Care_2010_Mar_29_33(3)_595-601.tar.gz |
المجموعة: |
CiteSeerX |
الوصف: |
OBJECTIVE — To simplify and improve the treatment of patients with type 1 diabetes, we ascertained whether the site of subcutaneous insulin infusion can be used for the measurement of glucose. RESEARCH DESIGN AND METHODS — Three special indwelling catheters (24gauge microperfusion [MP] catheters) were inserted into the subcutaneous adipose tissue of subjects with type 1 diabetes (n � 10; all C-peptide negative). One MP catheter was perfused with short-acting insulin (100 units/ml, Aspart) and used for insulin delivery and simultaneous glucose sampling during an overnight fast and after ingestion of a standard glucose load (75 g). As controls, the further two MP catheters were perfused with an insulin-free solution (5% mannitol) and used for glucose sampling only. Plasma glucose was measured frequently at the bedside. RESULTS — Insulin delivery with the MP catheter was adequate to achieve and maintain normoglycemia during fasting and after glucose ingestion. Tissue glucose concentrations derived with the insulin-perfused catheter agreed well with plasma glucose levels. Median correlation coefficient and median absolute relative difference values were found to be 0.93 (interquartile |
نوع الوثيقة: |
text |
وصف الملف: |
application/zip |
اللغة: |
English |
العلاقة: |
http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.356.7179Test |
حقوق: |
Metadata may be used without restrictions as long as the oai identifier remains attached to it. |
رقم الانضمام: |
edsbas.F225F52 |
قاعدة البيانات: |
BASE |